Recently, lymphocyte-to-monocyte ratio and mutations such as TP53, SRSF2, IDH2 and ASXL1 were also demonstrated to predict the prognosis of MDS [6–10]. The gene discussed is IDH2; the disease is myelodysplastic syndrome.